HF
PTLA

Hoxton Financial’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Hoxton Financial’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$4K Hold
189
– – ﹤0.01% 301
2015
Q4 		$10K Hold
189
– – ﹤0.01% 236
2015
Q3 		$8K Buy
+189
New +$9.12K ﹤0.01% 240

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hoxton Financial's PTLA Position: Q1 2016 in Review

Hoxton Financial held its Portola Pharmaceuticals, Inc. (PTLA) position steady in Q1 2016 at 189 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Hoxton Financial first reported a position in PTLA in Q3 2015 and has held it in 3 quarters since. The position peaked at $10K in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

  • Hoxton Financial held 189 shares of Portola Pharmaceuticals, Inc. worth $4K as of Q1 2016.
  • Hoxton Financial left its Portola Pharmaceuticals, Inc. share count unchanged in Q1 2016.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #301 holding.
  • Hoxton Financial first reported a position in Portola Pharmaceuticals, Inc. in Q3 2015 and has held it in 3 quarters since.
  • Hoxton Financial's Portola Pharmaceuticals, Inc. position peaked at $10K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.